Strata Skin Sciences ROE 2012-2025 | SSKN
Current and historical return on equity (ROE) values for Strata Skin Sciences (SSKN) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Strata Skin Sciences ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-09-30 | $-0.01B | $0.00B | -488.89% |
| 2025-06-30 | $-0.01B | $0.00B | -258.82% |
| 2025-03-31 | $-0.01B | $0.00B | -138.46% |
| 2024-12-31 | $-0.01B | $0.01B | -125.00% |
| 2024-09-30 | $-0.01B | $0.01B | -90.00% |
| 2024-06-30 | $-0.01B | $0.01B | -68.09% |
| 2024-03-31 | $-0.01B | $0.01B | -80.00% |
| 2023-12-31 | $-0.01B | $0.01B | -67.69% |
| 2023-09-30 | $-0.01B | $0.02B | -37.84% |
| 2023-06-30 | $-0.01B | $0.02B | -35.00% |
| 2023-03-31 | $-0.01B | $0.02B | -28.24% |
| 2022-12-31 | $-0.01B | $0.02B | -26.67% |
| 2022-09-30 | $-0.01B | $0.02B | -30.11% |
| 2022-06-30 | $-0.01B | $0.02B | -28.87% |
| 2022-03-31 | $0.00B | $0.02B | -15.84% |
| 2021-12-31 | $0.00B | $0.03B | -11.88% |
| 2021-09-30 | $0.00B | $0.03B | -7.84% |
| 2021-06-30 | $0.00B | $0.03B | -7.84% |
| 2021-03-31 | $-0.01B | $0.02B | -19.42% |
| 2020-12-31 | $0.00B | $0.03B | -14.95% |
| 2020-09-30 | $-0.01B | $0.03B | -18.18% |
| 2020-06-30 | $-0.01B | $0.03B | -17.70% |
| 2020-03-31 | $0.00B | $0.03B | -13.91% |
| 2019-12-31 | $0.00B | $0.03B | -13.68% |
| 2019-09-30 | $0.00B | $0.03B | -10.08% |
| 2019-06-30 | $0.00B | $0.03B | -9.76% |
| 2019-03-31 | $0.00B | $0.03B | -9.45% |
| 2018-12-31 | $0.00B | $0.03B | -13.68% |
| 2018-09-30 | $-0.01B | $0.03B | -30.19% |
| 2018-06-30 | $-0.02B | $0.03B | -86.60% |
| 2018-03-31 | $-0.02B | $0.02B | -110.53% |
| 2017-12-31 | $-0.02B | $0.02B | -121.74% |
| 2017-09-30 | $-0.02B | $0.02B | -112.50% |
| 2017-06-30 | $-0.01B | $0.01B | -42.86% |
| 2017-03-31 | $-0.01B | $0.01B | -32.79% |
| 2016-12-31 | $0.00B | $0.02B | -25.40% |
| 2016-09-30 | $0.00B | $0.02B | -25.00% |
| 2016-06-30 | $-0.01B | $0.02B | -87.50% |
| 2016-03-31 | $-0.02B | $0.02B | -118.92% |
| 2015-12-31 | $-0.03B | $0.02B | -167.16% |
| 2015-09-30 | $-0.03B | $0.02B | -209.52% |
| 2015-06-30 | $-0.02B | $0.03B | -148.39% |
| 2015-03-31 | $-0.01B | $0.01B | -133.33% |
| 2014-12-31 | $-0.02B | $0.01B | -150.00% |
| 2014-09-30 | $-0.01B | $0.02B | -155.56% |
| 2014-06-30 | $-0.02B | $0.01B | -245.16% |
| 2014-03-31 | $-0.03B | $0.01B | -257.14% |
| 2013-12-31 | $-0.03B | $0.01B | -176.27% |
| 2013-09-30 | $-0.03B | $0.01B | -166.15% |
| 2013-06-30 | $-0.03B | $0.02B | -136.99% |
| 2013-03-31 | $-0.02B | $0.02B | -124.32% |
| 2012-12-31 | $-0.02B | $0.01B | -117.33% |
| 2012-09-30 | $-0.02B | $0.02B | -92.31% |
| 2012-06-30 | $-0.02B | $0.02B | -95.65% |
| 2012-03-31 | $-0.02B | $0.02B | -91.67% |
| 2011-12-31 | $-0.02B | $0.03B | -84.85% |
| 2011-09-30 | $-0.02B | $0.02B | -83.17% |
| 2011-06-30 | $-0.02B | $0.02B | -67.23% |
| 2011-03-31 | $-0.02B | $0.03B | -65.57% |
| 2010-12-31 | $-0.02B | $0.03B | -63.49% |
| 2010-09-30 | $-0.02B | $0.04B | -67.74% |
| 2010-06-30 | $-0.02B | $0.03B | -75.00% |
| 2010-03-31 | $-0.02B | $0.03B | -85.11% |
| 2009-12-31 | $-0.02B | $0.03B | -102.70% |
| 2009-09-30 | $-0.02B | $0.03B | -115.25% |
| 2009-06-30 | $-0.02B | $0.01B | -120.75% |
| 2009-03-31 | $-0.02B | $0.01B | -119.30% |
| 2008-12-31 | $-0.02B | $0.02B | -107.94% |
| 2008-09-30 | $-0.02B | $0.02B | -92.75% |
| 2008-06-30 | $-0.02B | $0.01B | -81.08% |
| 2008-03-31 | $-0.01B | $0.02B | -66.67% |
| 2007-12-31 | $-0.01B | $0.02B | -60.00% |
| 2007-09-30 | $-0.01B | $0.02B | -55.00% |
| 2007-06-30 | $-0.01B | $0.02B | -59.70% |
| 2007-03-31 | $-0.01B | $0.02B | -62.50% |
| 2006-12-31 | $-0.01B | $0.02B | -65.57% |
| 2006-09-30 | $-0.01B | $0.01B | -75.86% |
| 2006-06-30 | $-0.01B | $0.01B | -115.79% |
| 2006-03-31 | $-0.01B | $0.02B | -160.00% |
| 2005-12-31 | $-0.01B | $0.02B | -400.00% |
| 2005-09-30 | $-0.01B | $-0.01B | 311.11% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.007B | $0.034B |
| Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $36.493B | 42.21 |
| Tempus AI (TEM) | United States | $11.621B | 0.00 |
| Doximity (DOCS) | United States | $7.649B | 31.50 |
| Hims & Hers Health (HIMS) | United States | $6.743B | 54.85 |
| IRhythm Holdings (IRTC) | United States | $5.166B | 0.00 |
| Hinge Health (HNGE) | United States | $3.350B | 0.00 |
| Privia Health (PRVA) | United States | $2.945B | 184.15 |
| 10x Genomics (TXG) | United States | $2.832B | 0.00 |
| Heartflow (HTFL) | United States | $2.739B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.307B | 38.17 |
| Omnicell (OMCL) | United States | $2.257B | 46.15 |
| Azenta (AZTA) | United States | $1.842B | 75.57 |
| Clover Health Investments (CLOV) | United States | $1.338B | 0.00 |
| Enovis (ENOV) | United States | $1.316B | 6.91 |
| Schrodinger (SDGR) | United States | $1.210B | 0.00 |
| Butterfly Network (BFLY) | United States | $1.139B | 0.00 |
| Phreesia (PHR) | United States | $0.955B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.860B | 0.00 |
| Talkspace (TALK) | United States | $0.671B | 135.00 |
| Standard BioTools (LAB) | United States | $0.596B | 0.00 |
| Claritev (CTEV) | United States | $0.477B | 0.00 |
| Evolent Health (EVH) | United States | $0.440B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.362B | 0.00 |
| Carlsmed (CARL) | United States | $0.352B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.318B | 0.00 |
| TruBridge (TBRG) | United States | $0.309B | 14.22 |
| Senseonics Holdings (SENS) | United States | $0.299B | 0.00 |
| CapsoVision (CV) | United States | $0.281B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.260B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.187B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.179B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.160B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.159B | 0.00 |
| CareCloud (CCLD) | United States | $0.123B | 6.74 |
| Outset Medical (OM) | United States | $0.093B | 0.00 |
| American Well (AMWL) | United States | $0.080B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.077B | 0.00 |
| Pulmonx (LUNG) | United States | $0.076B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.067B | 0.00 |
| HeartBeam (BEAT) | United States | $0.062B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.059B | 0.00 |
| 111 (YI) | China | $0.044B | 0.00 |
| Precipio (PRPO) | United States | $0.043B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.034B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.021B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.018B | 0.00 |
| Movano (MOVE) | United States | $0.014B | 0.00 |
| Zhongchao (ZCMD) | China | $0.011B | 0.00 |
| HeartSciences (HSCS) | United States | $0.011B | 0.00 |
| PROFUSA (PFSA) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.008B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |